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Abstract
Background: Prevalence of dyslipidemia is high and increases even in younger people. The key aim of this study
was to explore the group characteristics of patients in different durations of dyslipidemia and provide clues for the
management of dyslipidemia in Beijing.
Results: Patients with short duration of dyslipidemia were mainly characterized by relatively young age,
occupational groups, not eating or irregular eating breakfast, less physical activities, having the habit of smoking,
and 53.8% is with abnormal LDL-c, 10.4% is with abnormal HDL-c, and 51.5% is with abnormal TG. 54.6% of
patients with longer duration is with abnormal LDL-c, 12.8% of them is with abnormal HDL-c, and 57.1% is with
abnormal TG. They paid much more attentions to their health, tried to eat breakfast regularly and do more
physical activities, gave up smoking, and had regular breakfast, but increasing physiological disorders such as
elevated blood pressure and glucose appeared. Severe sequelaes (stroke, myocardial infarction) were mainly
observed in patients with the duration of more than 10 years. And in this group the proportions of patients with
LDL-c ≥ 4.15 mmol/L and TG ≥ 4.53 mmol/L are the highest among the three groups.
Conclusions: we should strengthen the tertiary prevention and improve the control rate of dyslipidemia in Beijing.
Health promotion programs such as tobacco control and physical exercise should be carried out for younger
patients.
Background
Dyslipidemia, a common lipid abnormality is characterized
by elevated lowdensity lipoprotein cholesterol (LDL-c),
elevated triglycerides (TGs), or low high density lipopro-
tein cholesterol (HDL-c) [1]. Prevalence of dyslipidemia is
high and becomes to increase even in younger people [2].
In addition to elevated LDL-c, both low HDL-c and ele-
vated TG are increasingly being recognized as indepen-
dent risk factors for coronary heart disease (CHD) [3,4].
Dyslipidemia is one of the leading causes of death and car-
diovascular morbidity in western countries [5]. Hyperten-
sion, dyslipidemia, endothelial dysfunction and oxidative
stress are the major pathologies involved in CVDs and
impose a great risk [6]. Dyslipidemia is responsible for
54% of population attributable risk for myocardial infarc-
tion (MI) [7,8]. Dyslipidemia is also an important contri-
butor to cardiovascular risk in people with metabolic
syndrome [6]. Dyslipidemia is consanguineously related
with life style [9]. Better high-density lipoprotein (HDL)
can be gotten through changing the lifestyle [10]. And
hypercholesterolaemia is the permissive factor that allows
other risk factors to operate [11]. If the TC decreased 1%,
the incidence of CHD will reduce 2%. And if TC decreased
10%, the mortality of CHD will reduce 13%~14% [12].
The importance of dyslipidemia management is based
on cardiovascular risk factors. Assessment of the patient’s
risk for coronary heart disease helps determine which
treatment should be initiated [13]. The lipid management
goal is also based on risk assessment and the manage-
ment of dyslipidemia doesn’t always require drug therapy.
Particularly, lifestyle modification is important for the
management of low HDL-C and TG [14]. We manage to
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durations of dyslipidemia through a cross-sectional inves-
tigation which will assess cardiovascular risk factors of
the dyslipidemia patients and provide clues for the pre-
vention and therapy of dyslipidemia in Beijing.
Methods
Survey methodology
A cross-sectional study was performed to research the
prevalence level of chronic diseases and risk factors in
Beijing in 2005, in which, the target people involved was
aged ≥ 18 years old and had been living in Beijing for at
least 6 months. In the study, 19216 individuals who
represented 19216 families involved in the survey with
multi-stage cluster sampling study, and this investigation
covered 162 communities of 54 sub districts in all 18
municipal districts. The sub districts were sampled with
probability proportional to size cluster sampling method
in each district. 16711(87.0%) subjects were valid and
used in consequent studies. And 2692 diagnosed dyslipi-
demia patients with complete duration information from
the 16711 valid participants were chosen for the corre-
spondence analysis in this study.
Our survey included a questionnaire, physical mea-
surements, blood pressure measurements and laboratory
tests to collect information. Before the investigation all
the people involved had signed the informed consents.
We used Calender 7600 autoanalyzer to test fasting lipid
components for the diagnosis of dyslipidemia in the
laboratory of Beijing CDC(the Center for Disease
Control and Prevention).
Diagnosis methods and a layered approach
Dyslipidemia was diagnosed as any abnormal status of
LDL-C, HDL-C and TG (based on the standard of ATPIII:
TG ≥ 1.70 mmol/L, LDL-c ≥ 3.46 mmol/L, HDL-c < 0.91
mmol/L), And basing on the standard of ATPIII, TG was
divided into four groups(TG < 1.70 mmol/L, 1.70 ≤ TG
< 2.27 mmol/L, 2.27 ≤ TG < 4.52 mmol/L, TG ≥ 4.53
mmol/L); LDL-c was divided into three groups(LDL-c
< 3.46 mmol/L, 3.46 ≤ LDL-c < 4.15 mmol/L, LDL-c
≥ 4.15 mmol/L); HDL-c was divided into three groups
(HDL-c < 0.91 mmol/L, 0.91 ≤ HDL-c < 1.56 mmol/L,
HDL-c ≥ 1.56 mmol/L). The duration of dyslipidemia was
calculated according to the date on which one was first
diagnosed as dyslipidemia patient. Body mass index (BMI)
was calculated as body weight divided by height squared
(kg/m
2). Lower-weight(L-W), normal-weight(N-W), over-
weight and obesity were defined as BMI < 18.5, 18.5 ≤
BMI < 25, 25 ≤ BMI < 30 and BMI ≥ 30, respectively.
Current smokers included regular and casual smokers
within the last month and were classified as non-
smoking, 0-9 cigarettes/day, 10-19 cigarettes/day, 20-29
cigarettes/day and ≥ 30 cigarettes/day. Drinking groups
included non-drinking (never drink or drink less than
1 time per month), occasional drinking (drink more
than 1 time per month but less than 2 times per week)
and frequent drinking (drink more than 2 times per
week). Lack of physical activities referred to less than 2
hour physical activities per week including walking, dan-
cing, running, swimming and court game, excluding
work purpose physical activities. Low-intake of calcium,
low-intake of fruit and vegetable and protein intake
were all based on food frequency questionnaire.
According to the measurement of blood pressure(BP),
we defined the normal BP, borderline hypertension, low-
grade hypertension, middle-grade hypertension and high-
grade hypertension as SBP < 130 mmHg and DBP < 85
mmHg, 130 mmHg ≤ SBP < 140 mmHg or 85 mmHg
≤ DBP < 90 mmHg, 140 mmHg ≤ SBP < 160 mmHg or
90 mmHg ≤ DBP < 100 mmHg, 160 mmHg ≤ SBP < 180
mmHg or 100 mmHg ≤ DBP < 110 mmHg, SBP ≥ 180
mmHg or DBP ≥ 110 mmHg. And according to the fast-
ing plasma glucose (FPG), normal FPG, impaired fasting
glucose(IFG) and diabetes were defined as FPG < 6.1
mmol/L, 6.1 mmol/L ≤ FPG < 7.0 mmol/L and FPG ≥ 7.0
mmol/L. We diagnosed metabolic syndrome (MS) as the
standard of ATPIII. The consideration of myocardial
infraction and stroke were according to the diagnosis of
local hospitals.
The sample size of each duration group was: “0-4 years”:
1816 (67.5%); “5-9 years”: 517 (19.2%); “ ≥ 10 years”:359
(13.3%).
Statistical analysis
All data were doubly input and checked with Epidata3.1
by a professional data recording company. Abnormal
values and missing values were checked (logic check) by
quality control group to ensure the data accuracy. SAS
software (version 9.1, SAS Institute (Shanghai) Co., Ltd.)
was used to perform univariate analysis and multiple
correspondence analysis. Prior to multiple correspon-
dence analysis, univariate analysis were made to find sig-
nificant variables. Nonparametric test was used to
explore the correlation between a particular correlated
factors and durations of dyslipidemia. We performed
Mann-Whitney with the variables classified as two
levels, and Kruskal-Wallis for variables classified as mul-
tilevel out of orders (such as occupation), and Spearman
rank correlation analysis for variables classified as multi-
level orders.
Correspondence analysis is used to analyze the differ-
ences among every sort of one same variable and the
corresponding relationship among every sort of variable.
This method is converting an original data matrix X =
(x) nm contains n subjects and m variables into another
matrix Z = (z) nm, and also making R = Z’Z (covariance
matrix analyzing the relationship among variables) and
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among subjects) have the same non-zero eigenvalue by
utilizing a sort of data transformation method. The hori-
zontal axis of the correspondence analysis graph is the
first dimensionality, and the second dimensionality is
the vertical axis. The distance between the two variables
can indicate the approximate relationship between the
two variables [15,16].
Results
The awareness and control rates of dyslipidemia are low
in Beijing
According to the new test results of TC, TG, LDL,
HDL, there are 6709 dyslipidemia patients among 16711
s u b j e c t s .A n dt h ep r e v a l e n c er a t eo fd y s l i p i d e m i ai s
40.15%. And according to the questionnaire, the aware-
ness, control rates of dyslipidemia were 43.79% and
17.20% respectively. 17.35% of the patients control dysli-
pidemia through taking drugs, 3.61% of the patients
through dietary restriction and 10.51% through physical
exercises. Among 6709 dyslipidemia patients, 2692 cases
can recall when and where their dyslipidermia were
diagnosed while 249 patients can’t. And 3768 patients
are newly diagnosed through our investigation. Among
the 2692 patients with complete duration information,
7.0%(188) was diagnosed in Community Health Station,
13.2%(354) was diagnosed in Health service centers in
Communities, 48.0%(1293) was diagnosed in Chinese
Level II Hospital, and 31.8%(853) was diagnosed in
Tertiary Health Care. And the lipid degrees and BMI of
dyslipidemia patients with different durations is shown
in table 1.
The LDL-c, HDL-c and TG levels of patients with the
0-4 years duration are 3.53 ± 0.96 mmol/L, 1.25 ± 0.32
mmol/L, 2.17 ± 1.72 mmol/L. The LDL-c, HDL-c and
TG levels of patients with the 5-9 years duration are
3.56 ± 0.98 mmol/L, 1.23 ± 0.31 mmol/L, 2.37 ± 1.79
mmol/L. The LDL-c, HDL-c and TG levels of patients
with the ≥ 10 years duration are 3.56 ± 0.961.19 mmol/
L, 1.26 ± 0.36 mmol/L, 2.38 ± 1.89 mmol/L. 53.8% of
patients in 0-4 years duration is with abnormal LDL-c,
10.4% is with abnormal HDL-c, and 51.5% is with
abnormal TG, while 47.2% is overweight and 27.3% is
obesity; 54.6% of patients in 5-9 years duration is with
abnormal LDL-c, 12.8% is with abnormal HDL-c, and
57.1% is with abnormal TG, while 46.8% is overweight
and 30.2% is obesity; 56.9% of patients in 10 years or
more duration is with abnormal LDL-c, 12.6% is with
abnormal HDL-c, and 53.6% is with abnormal TG, while
43.3% is overweight and 33.2% is obesity. The propor-
tion of patients with LDL-c ≥ 4.15 mmol/L is increasing
with the increasing duration among the three groups
while the proportion of patients with 3.46 mmol/L
≤ LDL-c < 4.15 mmol/L is decreasing. The proportion
of obese people is increasing with the increasing dura-
tion among the three groups.
Distribution of correlated factors and diseases in patients
with different durations of dyslipidemia
Nineteen major factors were enrolled in the initial uni-
variate analysis. These factors were living area, gender,
educational degree, age group, occupation, current
smoking status, status of breakfast, alcohol intake, status
of physical activities, oil intake, degree of salt intake,
low-intake of calcium, low-intake of vegetable, ineffi-
cient protein intake, degree of total cholesterol, degree
of HDL-C, degree of TG, degree of LDL-C, BMI. In the
same way, the correlated diseases (hypertension, dia-
betes, myocardial infraction, stroke, metabolic syndrome
and centripetal obesity) of dyslipidemia were chosen to
Table 1 the lipid level and BMI of dyslipidemia patients with different durations
0~4 years 5~9 years 10 years~ Statistic P value
n% n % n %
LDL-c (mmol/L) <3.46 839 46.2 235 45.4 154 43.1
3.46~ 544 30.0 141 27.3 95 26.5
≥ 4.15 433 23.8 141 27.3 109 30.4 0.037 0.057
HDL-c (mmol/L) <0.91 189 10.4 66 12.8 45 12.6
0.91~ 1365 75.2 378 73.1 260 72.6
1.56~ 262 14.4 73 14.1 53 14.8 -0.020 0.308
TG (mmol/L) <1.70 881 48.5 222 42.9 166 46.4
1.70~ 352 19.4 105 20.3 63 17.6
2.27~ 457 25.2 144 27.9 94 26.3
≥ 4.53 126 6.9 46 8.9 35 9.8 0.045 0.020
BMI L-W 12 0.7 1 0.2 1 0.3
N-W 449 24.7 118 22.8 83 23.2
overweight 859 47.3 242 46.8 155 43.3
obesity 496 27.3 156 30.2 119 33.2 0.043 0.026
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assembling mode. The significant statistic results were
shown in Table 2 and Table 3.
Multiple correspondence analysis on the durations of
dyslipidemia and correlated factors
We excluded the insignificant factors in univariate ana-
lysis, and carried out multiple correspondence analysis
on durations of dyslipidemia. Multiple correspondence
analysis graph was shown in Fig 1. From the distance
between codes which present the three durations of dys-
lipidemia and their risk factors at different level shown
in Fig 1, we found that patients with duration of dyslipi-
demia less than 5 years were correlated with the identi-
ties of living in rural area, young to middle aged,
worker, civil servant or farmer, not eating or irregular
eating breakfast, less physical exercise, occasionally or
often smoking; Patients with duration of 5-9 years were
mainly assembled with living in urban area, 50-59 years
old, eating breakfast every day, no smoking or heavy
smoking, doing more physical exercises; And patients
with duration of dyslipidemia ≥ 10 years concentrated
mainly on retired or unemployed citizens, aged above
60 years old.
We selected the significant statistic factors listed in
t a b l e2t op e r f o r mm u l t i p l ec o r r e s p o n d e n c ea n a l y s i s .
Multiple correspondence analysis graph was shown in
Fig 2. From the distance between the durations of dysli-
pidemia and their risk factors at different level according
to Fig 2, we can find that patients with the duration less
then 5 years was mainly assembled with normal in
metabolism, blood glucose and blood pressure, without
myocardial infarction stroke or centripetal obesity.
Patients with the duration of dyslipidemia between 5-9
years gradually depart from normal status with critical
hypertension, impaired fasting glucose(IFG), and get
close to metabolic syndrome. And patients with dura-
tion more than 10 years were much closed with hyper-
tension, diabetes mellitus(DM), myocardial infarction
and stroke.
Discussion
As an extension to principal component analysis, corre-
spondence analysis is a kind of descriptive multi-variable
analysis method, factor analysis and canonical correla-
tion analysis. Through projection from vector point of
high dimensional space to lower dimensional space,
multiple correspondence analysis can be used to clearly
illustrate correlations among multiple variables in one
simple two dimension chart through projection from
vector point of high dimensional space to lower dimen-
sional space, therefore, can generate some benefits like
Table 2 Distribution of correlated factors in patients with different durations of dyslipidemia
code 0~4 years 5~9 years 10 years~ Statistic P value
n%n%n%
career CARE1 worker 188 76.1 34 13.8 25 10.1
CARE2 civil servant 834 69.7 252 21.1 111 9.3
CARE3 resident 464 57.0 174 21.4 176 21.6
CARE4 farmer 157 74.0 33 15.6 22 10.4
CARE5 civil servant 173 78.2 24 10.9 24 10.9 77.07 <0.001
age AGE1 18~ 291 84.6 41 11.9 12 3.5
AGE2 40~ 629 74.7 150 17.8 63 7.5
AGE3 50~ 597 63.7 203 21.7 137 14.6
AGE4 60~ 209 55.8 83 22.1 83 22.1
AGE5 70~ 90 46.7 40 20.7 63 32.6 0.24 <0.001
site SUB Urban 1183 65.0 362 19.9 275 15.1
CITY Rural 633 72.7 155 17.8 83 9.5 -4.31 <0.001
smoking group SMK0 none 1305 69.5 342 18.2 230 12.3
SMK1 1~/d 134 62.6 45 21.0 35 16.4
SMK2 10~/d 160 66.4 47 19.5 34 14.1
SMK3 20~/d 159 61.4 64. 24.7 36 13.9
SMK4 30~/d 57 58.2 19 19.4 22 22.4 0.07 <0.001
Exercise LACK-S Lack 1191 65.7 357 19.7 265 14.6
ACT enough 621 71.4 156 18.0 92 10.6 -3.21 0.001
brfst BRFST1 none 116 73.0 29 18.2 14 8.8
BRFST2 1-3 t/w 109 73.6 25 16.9 14 9.5
BRFST3 4-6 t/w 129 75.0 31 18.0 12 7.0
BRFST4 everyday 1462 66.1 432 19.5 318 14.4 0.69 <0.001
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and saving calculating time, etc [15,16]. In our study the
multiple variables assemble obviously.
The INTERHEART study also showed that nine tradi-
tional risk factors (smoking, hypertension, diabetes,
obesity, diet, physical activity, alcohol consumption,
psychosocial factors, and dyslipidemia) contributed to
the high CHD burden in the South Asian population as
in other countries. From the review of the report ‘the
nutrition and health status of Chinese’ which was pub-
lished by medical ministry of People’s Republic of China
in Oct, 2004, we knew that the prevalence of chronic
Table 3 Distribution of the correlated diseases in patients with different duration of dyslipidemia
code 0~4 years 5~9 years 10 years~ Statistic P value
n%n%n%
HP HP0 normal 400 78.3 73 14.3 38 7.4
HP1 borderline 648 66.9 199 20.5 122 12.6
HP2 low-grade 492 65.3 152 20.2 109 14.5
HP3 middle-grade 197 60.2 66 20.2 64 19.6
HP4 high-grade 69 57.5 26 21.7 25 20.8 0.12 <0.001
DM DM0 normal 1341 70.1 350 18.3 223 11.7
IFG IFP 171 67.6 49 19.4 33 13.0
DM DM 289 57.4 114 22.7 100 19.9 0.10 <0.001
MS MS0 not happened 1164 70.3 294 17.8 197 11.9
MS1 happened 628 62.5 219 21.8 158 15.7 -4.21 <0.001
AMI AMI0 not happened 1735 68.5 481 19.0 315 12.5
AMI1 happened 32 38.1 20 23.8 32 38.1 -6.57 <0.001
STROKE STR0 not happened 1699 68.6 475 19.2 304 12.2
STR1 happened 75 50.0 28 18.7 47 31.3 -5.55 <0.001
Figure 1 Multiple correspondence analyses of the duration of dyslipidemia and its correlated factors. The relevant abbreviations existed
in Figure 1 are according to the codes presented in Table 2.
Liu et al. Lipids in Health and Disease 2010, 9:115
http://www.lipidworld.com/content/9/1/115
Page 5 of 8disease such as hypertension, diabetes and dyslipidemia
ascended rapidly and the unhealthy lifestyle was the
main risk factor. Many researches had mentioned that
direct or indirect smoking was one of the most impor-
tant risk factors of dyslipidemia [17-19]. And the same
Lack of physical activities and the habit of sedentariness
were another risk factor of dyslipidemia [20]. And study
suggested high prevalence of dyslipidemia in all age
groups both in males and females and the prevalences
were increasing with age [21]. In our study we also
found that patients with shorter duration were closely
related with lack of physical activities and having the
habit of smoking. But the elder patients began to pay
more attention to their health. And they tried to change
their unhealthy lifestyle such as eating breakfast regu-
larly, giving up smoking and doing more physical exer-
cises, but metabolic syndrome had taken place in this
period and critical hypertension and IFG happened dur-
ing this period.
Tenkanen L’ data showed that patients with dyslipide-
mia and features associated with the metabolic syndrome
(BMI and TG in the highest tertiles) [22]. Hypertension,
diabetes, and dyslipidemia are all factors individually
associated with increased risk for mortality from cardio-
vascular disease and all-cause mortality [23]. Some type
of diet was tested in clinical trials in Italy and shown to
lower blood pressure and improve dyslipidemia [24]. For-
sythe’s study had suggested that a healthier diet favorably
and strongly affects dyslipidemia and hypertension, even
in obese patients who do not lose weight [20]. It has been
indicated the combination of aerobic and resistance exer-
cise may provide greater benefit in people with dyslipide-
mia and other components of the metabolic syndrome
because of the combined effects of reduced adiposity,
increased muscle mass, and improved myocyte function,
including increased oxidative capacity [25]. According to
the characteristics of patients with different duration of
dyslipidemia in Beijing, We found the clues for the stra-
tegies about the prevention of dyslipidemia. At the earlier
of dyslipidemia, patients were relatively young, lack of
healthy sense, with the unhealthy life-style. With the
development of dyslipidemia patients gradually suffered
from other chronic diseases and they began to pay more
attention to their health and change their unhealthy
Figure 2 Multiple correspondence analyses of the duration of dyslipidemia and its correlated diseases. The relevant abbreviations
existed in Figure 2 are according to the codes presented in Table 3.
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dial infarction and stroke were inevitable. According to
those characters, the strategies about the prevention of
should be developed with changing young people’sr i s k
behavior. Because of the clustering of dyslipidemia, dia-
betes, hypertension and obesity, a comprehensive strategy
should be made to improve the prevention of cardiovas-
cular disease.
Because many different risk factors affect dyslipidemia
patients with different duration, potentially complemen-
tary mechanisms of action, combination control may
offer additional beneficial effects to patients with differ-
ent duration of dyslipidemia. This study demonstrates
that different duration of dyslipidemia with different risk
factors which can effectively improve multiple interven-
tion measures to a greater extent in patients with dysli-
pidemia, without significantly increasing the risk for
adverse events commonly associated with unified inter-
vention model. These findings in our paper have impor-
tant public health implications for the prevention and
treatments of dyslipidemia.
Conclusions
According to our research, we should strengthen the
tertiary prevention and improve the control rate of dys-
lipidemia in Beijing. Community physicians should take
effective measures to control blood lipids for patients
with dyslipidemia. We should strengthen the prevention
and treatment of dyslipidemia for younger people, Parti-
cularly for the working groups and community retired
residents. Health promotion programs such as tobacco
control and physical exercise should be carried out for
younger patients. Community hospitals should establish
files with chronic diseases patients. The blood lipids,
blood glucose, blood pressure should strictly controlled
for the dyslipidemia patients with the duration of more
than five years and then we can prevent the serious
complications such as myocardial infarction and stroke.
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